CompletedNot Applicable

Exacerbation of Erythema Following PDT in Patients With Probable Capillary Malformation-Arteriovenous Malformation Syndrome: Retrospective Analysis of Ultrasound and Clinical Characteristics.

China16 participantsStarted 2024-03-01

Plain-language summary

This study aims to reduce the misdiagnosis rate of PWSs and improve the diagnosis of CM-AVM using ultrasound. Furthermore, we seek to provide more evidence-based recommendations for the treatment of patients with probable CM-AVM syndrome, particularly those presenting with erythema.

Who can participate

Age range1 Year

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients who were greater than or equal to 1 year old at the time of their first HMME-PDT treatment. * Patients who experiencing exacerbation of clinical symptoms, such as darker coloration than before treatment. * Patients who have undergone one or more HMME-PDT treatments. ④ Patients with complete basic information and treatment-related information.

What they're measuring

ultrasound characteristics

Timeframe: The efficacy evaluation will be conducted 3 months after the completion of the 1st HMME-PDT treatment.

Trial details

NCT IDNCT06985563

SponsorSecond Affiliated Hospital of Xi'an Jiaotong University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-06-01

View on ClinicalTrials.gov More Probable Capillary Malformation-Arteriovenous Malformation Syndrome trials